Searchable abstracts of presentations at key conferences in endocrinology

ea0067o8 | Oral Presentations | EYES2019

Toxic adenoma as a rare cause of hyperthyroidism in a prepubertal boy

Kosteria Ioanna , Vassilakis Ioannis-Anargyros , Koulenti Marina , Voutetakis Antonios , Kanaka-Gantenbein Christina

Background: Toxic adenoma (TA) is a rare cause of hyperthyroidism in children, representing less than 3% of cases, more frequently affecting girls. The risk of malignancy in pediatric autonomous nodules is unknown. Despite current guidelines on the management of TA, published case series reveal discrepancies in medical practice.Case presentation: We report a case of TA in a 7-year old boy, incidentally detected as a palpable mass during examination for l...

ea0041ep1104 | Thyroid cancer | ECE2016

Thyroid cancer in hyperthyroid patients treated by surgery

Domingues A L , Rodrigues E , Saavedra A , Matos Lima L , Carvalho D

Introduction: The association of hyperthyroidism and thyroid cancer (TC) is controversial with prevalences in the literature varying from 1.6 to 32.8%. The aim of this work was to evaluate the prevalence of TC in hyperthyroid patients submitted to surgery and to find differences between the tumors according to the type of hyperthyroidism.Material and methods: retrospective study to evaluate clinical and histopathological data of all hyperthyroid patients...

ea0050p399 | Thyroid | SFEBES2017

Autoantibodies to the thyrotropin receptor in Alemtuzumab-induced thyroid autoimmunity: determination of their biological activity, and possible role as predictive marker of disease

Muller Ilaria , Willis Mark , Healy Sarah , Nasser Taha , Zhang Lei , Draman Mohd Shazli , Taylor Peter , Robertson Neil , Ludgate Marian , Dayan Colin

Background: Alemtuzumab (ALTZ) is a humanised monoclonal anti-CD52 antibody used as effective treatment for relapsing/remitting multiple sclerosis (MS), causing panlymphopenia with subsequent lymphocyte repopulation. Unfortunately, around 40% of patients develop secondary humoral autoimmunity, mainly affecting the thyroid gland. Anti-thyrotropin-receptor (TSHR) autoantibodies (TRAb) can stimulate (TSAb), block (TBAb) or not affect (‘neutral’) TSHR function, with TSAb...

ea0050p399 | Thyroid | SFEBES2017

Autoantibodies to the thyrotropin receptor in Alemtuzumab-induced thyroid autoimmunity: determination of their biological activity, and possible role as predictive marker of disease

Muller Ilaria , Willis Mark , Healy Sarah , Nasser Taha , Zhang Lei , Draman Mohd Shazli , Taylor Peter , Robertson Neil , Ludgate Marian , Dayan Colin

Background: Alemtuzumab (ALTZ) is a humanised monoclonal anti-CD52 antibody used as effective treatment for relapsing/remitting multiple sclerosis (MS), causing panlymphopenia with subsequent lymphocyte repopulation. Unfortunately, around 40% of patients develop secondary humoral autoimmunity, mainly affecting the thyroid gland. Anti-thyrotropin-receptor (TSHR) autoantibodies (TRAb) can stimulate (TSAb), block (TBAb) or not affect (‘neutral’) TSHR function, with TSAb...

ea0032p413 | Diabetes | ECE2013

Cardiovascular risk and prevalence of metabolic syndrome in LADA patients depending on thyroid autoimmunity presence

Reghina Aura Diana , Constantin Madalina , Georgescu Olivia , Nistor Madalina , Olaru Ramona , Florea Suzana , Fica Simona

Background: Latent autoimmune diabetes in adults (LADA) is a form of autoimmune diabetes with a slower decline of β cell function and distinct features from type 1 and type 2 diabetes. LADA is also a very heterogenic group. Frequently LADA is associated with other autoimmune diseases especially endocrine diseases.Aim: To evaluate prevalence of thyroid autoimmunity (TA) and its impact on cardiovascular risk and metabolic syndrome in LADA patients.</p...

ea0020p148 | Thyroid | ECE2009

Incidental thyroid carcinoma in patients with thyrotoxicosis

Isik Serhat , Berker Dilek , Aydin Yusuf , Ozuguz Ufuk , Akcil Gulhan , Delibasi Tuncay , Guler Serdar

Objective: Thyroid malignancy detected incidentally in patients who underwent surgery for thyrotoxicosis has been reported at different rates. The aim of this study was to investigate the rate of incidental thyroid carcinoma (ITC) in thyrotoxic patients underwent surgery in our institution.Methods: The prevalence of ITC was investigated in patients who underwent surgery for Graves’ disease (GD), toxic adenoma (TA) or toxic multinodular goiter (TMNG)...

ea0016p216 | Diabetes and cardiovascular diseases | ECE2008

Effects of testosterone administration in male patients with heart failure with and without hypogonadism

Massaro Rosalba , Marazzi Giuseppe , Caminiti Giuseppe , Miceli Marco , Ribaudo Maria Cristina , Volterrani Maurizio , Rosano Giuseppe

Background: Testosterone administration (TA) can improve exercise capacity and glucose metabolism of males patients (pts) with chronic heart failure (CHF). It is not known whether testosterone supplementation benefits only CHF subjects with hypogonadism.Aim: To compare effects of TA in male pts with CHF with and without testosterone deficiency.Methods: Fifty-six males patients (median age 64.2±9.6), ejection fraction (EF) 36&#...

ea0056p1076 | Thyroid (non-cancer) | ECE2018

Effectiveness of radioiodine treatment for toxic adenoma

Sofia Osorio Ana , Filipa Martins Ana , Vaz de Castro Raquel , Gomes Vania , Faria Carolina , Nobre Ema , Antoine Ferreira Mickael , Cantinho Guilhermina , Joao Bugalho Maria

Objective: The purpose of this study was to assess clinical outcomes of patients with toxic adenoma (TA) treated with Radioactive Iodine (RAIT) in a tertiary hospital over a period of 8 years. We also analysed the influence of age, gender, TSH at diagnosis and anti-thyroid drugs (ATD) previous to RAIT on the cure rate.Methods: Retrospective analysis of clinical records of all patients with TA submitted to RAIT between 2008 and 2015. The influence of demo...

ea0058p030 | Miscellaneous Endocrinology | BSPED2018

Fertility preservation for transgender adolescents: The parent’s view

Walton-Betancourth Sandra , Monti Elena , Adu-Gyamfi Kirpal , Roberts Alice , Clarkson Kerry , Ward Stephanie , Butler Gary

Background: Fertility preservation (FP) amongst transgender adolescents (TA) is receiving more attention as individuals are transitioning at younger ages. Parents have a key role at exploring options for their children and are usually the ones responsible for consenting to interventions. Our aim was to explore parent’s attitudes regarding their offspring parenthood goals, FP counselling and perceived barriers to successful gamete banking.Methods: Pa...

ea0070aep801 | Reproductive and Developmental Endocrinology | ECE2020

11-Ketotestosterone is the Predominant Androgen in Castration Resistant Prostate Cancer

Snaterse Gido , van Dessel Lisanne F , van Riet Job , Taylor Angela E , Visser Jenny A , Arlt Wiebke , Lolkema Martijn P , Hofland Hans

Background: The treatment of metastatic castration-resistant prostate cancer (CRPC) remains dependent on Androgen Receptor (AR) mediated signalling, thus understanding all components involved in testosterone signalling in these men is of utmost importance. Recent studies have identified 11-ketotestosterone (11 KT) as a potent androgen receptor (AR) agonist present in humans. However, it is unknown if 11 KT is present at physiologically relevant concentrations in CRPC patients....